The National Health Regulatory Authority (NHRA) of Bahrain has officially announced the implementation of ADWEYA, an advanced digital platform aimed at optimizing pharmaceutical regulatory processes.

🌐 Key Benefits:
✅ Enhanced efficiency in regulatory submissions
✅ Faster turnaround times for registration, renewals, and product variations
✅ Improved transparency and user experience

🗓️ Implementation Phases:
🔹 Phase 1 (Starting June 1, 2025):
Account creation, submission of manufacturing site registrations, renewals, line additions, and initial health product registrations.
🔹 Phase 2:
Pharmaceutical product registrations, renewals, and variations.

👉 Click here to access the ''ADWEYA'' https://adweya.nhra.bh/

Follow MedRAIS for more regulatory updates! 📌